Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

norgine bv - kalijev klorid; natrijev hidrogenkarbonat; natrijev klorid; makrogol 3350 - prašek za peroralno raztopino - kalijev klorid 23,3 mg / 1 vrečica  natrijev hidrogenkarbonat89,3 mg / 1 vrečica  natrijev klorid175,4 mg / 1 vrečica  makrogol 33506560 mg / 1 vrečica; natrijev hidrogenkarbonat 89,3 mg / 1 vrečica  natrijev klorid175,4 mg / 1 vrečica  makrogol 33506560 mg / 1 vrečica; natrijev klorid 175,4 mg / 1 vrečica  makrogol 33506560 mg / 1 vrečica; makrogol 3350 - makrogol, kombinacije

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international bv - indoksakarb - ectoparasiticides za lokalno uporabo, vključno. insekticidi, indoksakarb - dogs; cats - zdravljenje in preprečevanje infestacij bolh. za pse in mačke: zdravljenje in preprečevanje infestacij bolh. zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa. razvoj stopenj bolh v neposredni okolici hišne živali se uniči po stiku s hišnimi živalmi, ki jih zdravimo z activylom.

Evropska unija - slovenščina - EMA (European Medicines Agency)

norgine b.v. - železov maltol - anemija, pomanjkanje železa - antianemični preparati - feraccru je navedeno pri odraslih za zdravljenje pomanjkanja železa.

Evropska unija - slovenščina - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - prašiči - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

paracetamol; orfenadrin - tableta - paracetamol 450 mg / 1 tableta  orfenadrin35 mg / 1 tableta; orfenadrin 35 mg / 1 tableta - orfenadrin, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

paracetamol; orfenadrin - tableta - paracetamol 450 mg / 1 tableta  orfenadrin35 mg / 1 tableta; orfenadrin 35 mg / 1 tableta - orfenadrin, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alfasan nederland bv kuipersweg 9 3449 ja woerden nizozemska tel: 0031 348 -

Evropska unija - slovenščina - EMA (European Medicines Agency)

eurocept international bv - kargluminska kislina - hyperammonemia; amino acid metabolism, inborn errors - drugi zdravljene bolezni prebavil in presnove izdelki, - ucedane is indicated in treatment of:hyperammonaemia due to n-acetylglutamate synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.

Evropska unija - slovenščina - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

synthon bv - levetiracetam - filmsko obložena tableta - levetiracetam 250 mg / 1 tableta - levetiracetam